I've just bought more shares, backed up my words with action. The cells worked boys and girls!!! The science worked!!! What an opportunity we have here. Risked has reduced because the science worked (SI might have picked the wrong primary endpoint, trying to protect the shareholders). Risk has also reduced for CLBP, because it is the same cells. Will be interesting to see why there is a reduced mortality, probably due to reduced inflammation OR increased tissue repair?
Not financial advice.
Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-232
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.005(0.54%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 93.0¢ | 93.5¢ | 91.5¢ | $1.473M | 1.596M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32370 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 60258 | 5 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |